The Agency for Science, Technology and Research
Signal active
Investment Firm
Overview
The Agency for Science, Technology and Research (ASTAR) is the lead agency for fostering world-class scientific research and talent for a vibrant knowledge-based and innovation-driven Singapore. ASTAR oversees 18 biomedical sciences and physical sciences and engineering research entities, located in Biopolis and Fusionopolis as well as their immediate vicinity.
A*STAR supports Singapore's key economic clusters by providing intellectual, human and industrial capital to its partners in industry. It also supports extramural research in the universities, hospitals, research centres, and with other local and international partners.
Highlights
Founded
1987
Industry
Biotechnology
Employees
5001-10000
Investment
4
Lead Investment
0
Exits
undefined
Stages
Late Stage Venture, Early Stage Venture
Investor Type
N/A
Location
Asia
Contact Information
Social
Profile Resume
The Agency for Science, Technology and Research, established in 1987 and headquartered in Asia., specializes in Late Stage Venture, Early Stage Venture investments across Biotechnology, Life Science, Health Care, Financial Services, Venture Capital, FinTech, Information and Communications Technology (ICT), Finance, Sales, Logistics. Their recent investments include Mirxes, EDBI, Mitsui & Co, China Fellow Partners, Nalagenetics. The highest investment round they participated in was $4.9B. Among their most notable exits are Mirxes and EDBI. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
The Agency for Science, Technology and Research has made 4 investments. Their most recent investment was on Jul 25, 2023, when Mirxes raised $50.0M.
investments
4
Diversity investments
0
Lead investments
0
Number of exits
undefined
Investments
4
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Oct 12, 2021 | AUM Biosciences | Biotechnology | 27.0M |
| Oct 27, 2021 | Sentient.io | Information Technology | null |
| Mar 25, 2022 | Nalagenetics | Biotechnology | 12.6M |
| Jul 25, 2023 | Mirxes | Biotechnology | 50.0M |
Exits
0
Funding Timeline
Funding rounds
4
Investors
3
Funds
0
Funding Rounds
4
The Agency for Science, Technology and Research has raised 4 rounds. Their latest funding was raised on Jul 25, 2023 from a Series D - Mirxes round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Oct 12, 2021 | Series A - AUM Biosciences | - | 27.0M | - |
| Oct 27, 2021 | Series B - Sentient.io | - | 0 | - |
| Mar 25, 2022 | Series A - Nalagenetics | - | 12.6M | - |
| Jul 25, 2023 | Series D - Mirxes | - | 50.0M | - |
Investors
3
The Agency for Science, Technology and Research is funded by 3 investor(s). Integra Partners and Trendlines Group Kantor are the most recent investors.
| Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|
Hafnium Hafaway | No | Venture Round - The Agency for Science, Technology and Research | 62.0M |
Trendlines Group | No | Venture Round - The Agency for Science, Technology and Research | 62.0M |
Integra Partners | No | Venture Round - The Agency for Science, Technology and Research | 62.0M |
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.